We are live on ! Find out more
JNJ icon

Johnson & Johnson

1,976 hedge funds and large institutions have $198B invested in Johnson & Johnson in 2014 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 732 increasing their positions, 972 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 41

8% more capital invested

Capital invested by funds: $185B → $198B (+$13.9B)

2% more funds holding in top 10

Funds holding in top 10: 675688 (+13)

0.49% more ownership

Funds ownership: 66.51%67% (+0.49%)

0% more funds holding

Funds holding: 1,9731,976 (+3)

25% less repeat investments, than reductions

Existing positions increased: 732 | Existing positions reduced: 972

26% less call options, than puts

Call options by funds: $1.09B | Put options by funds: $1.48B

Holders
1,976
Holders Change
+3
Holders Change %
+0.15%
% of All Funds
56.77%
Holding in Top 10
688
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+1.93%
% of All Funds
19.76%
New
54
Increased
732
Reduced
972
Closed
41
Calls
$1.09B
Puts
$1.48B
Net Calls
-$385M
Net Calls Change
-$512M
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
726
Maple Capital Management
Vermont
$9.61M -$13.6K -135 -0.1%
WAM
727
Wood Asset Management
Florida
$9.6M -$1.09M -10,818 -11%
HVIA
728
Hudson Valley Investment Advisors
New York
$9.58M -$343K -3,398 -4%
FNT
729
First National Trust
Pennsylvania
$9.57M +$293K +2,897 +3%
BOIA
730
Bush ODonnell Investment Advisors
Missouri
$9.57M -$1.91M -18,896 -17%
PCM
731
Palisade Capital Management
New Jersey
$9.55M -$487K -4,820 -5%
TAM
732
Taurus Asset Management
New York
$9.55M -$139K -1,375 -1%
CIP
733
Convergence Investment Partners
Florida
$9.55M -$937K -9,270 -9%
CAMI
734
Concord Asset Management (Illinois)
Illinois
$9.53M -$55.1K -545 -0.6%
TFF
735
Timothy F. Fidgeon
$9.53M +$4.85K +48 +0.1%
HCMT
736
Highland Capital Management (Tennessee)
Tennessee
$9.52M -$101K -1,000 -1%
WCM
737
Wallace Capital Management
Texas
$9.45M +$251K +2,488 +3%
Two Sigma Investments
738
Two Sigma Investments
New York
$9.43M +$9.11M +90,110 New
PC
739
Polar Capital
United Kingdom
$9.41M -$1.01M -10,000 -10%
SCM
740
Stonebridge Capital Management
California
$9.37M +$165K +1,633 +2%
GIP
741
Granite Investment Partners
California
$9.34M -$339K -3,350 -4%
CEI
742
Clark Estates Inc
New York
$9.34M -$8.09M -80,000 -47%
MCC
743
Mid Continent Capital
Illinois
$9.32M +$202K +1,995 +2%
TSS
744
Thomas Story & Son
Indiana
$9.29M
FAAS
745
First Allied Advisory Services
California
$9.28M +$184K +1,818 +2%
TIM
746
Thompson Investment Management
Wisconsin
$9.27M -$117K -1,159 -1%
FHA
747
First Horizon Advisors
Tennessee
$9.26M +$477K +4,721 +6%
GIP
748
Greatmark Investment Partners
Georgia
$9.21M +$49.7K +492 +0.6%
UAM
749
UAS Asset Management
New York
$9.21M -$1.05M -10,339 -11%
JPMIA
750
J.P. Marvel Investment Advisors
Massachusetts
$9.18M -$209K -2,070 -2%

JNJ Hedge Fund Activity: Q2 2014 in Review

1,976 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2014, worth a combined $198B — up 7.5% from $185B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new JNJ positions and 41 closed out — a net gain of 13 holders — while 732 added to existing stakes and 972 trimmed.

The largest buyer was Norges Bank, adding an estimated $2.09B. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $331M.

  • 1,976 institutional investors held Johnson & Johnson (JNJ) as of Q2 2014, up from 1,973 in Q1 2014.
  • Funds reported $198B of Johnson & Johnson stock for Q2 2014, up 7.5% quarter-over-quarter.
  • 54 funds opened new Johnson & Johnson positions in Q2 2014 and 41 closed out, a net change of +13 holders.
  • The largest Johnson & Johnson buyer in Q2 2014 was Norges Bank, an estimated $2.09B added.
  • The largest Johnson & Johnson seller in Q2 2014 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $331M sold.

Based on aggregated 13F filings for Q2 2014.